Professor Susanna Price, Chair of the European Society of Cardiology’s Advocacy Committee, advocates for improved early detection and addressing inequalities in cardiovascular disease prevention, the leading cause of death worldwide.
Charles Taylor, Founder and Chief Technology Officer at HeartFlow, explores how artificial intelligence (AI) is helping to fix the gender disparities in healthcare.
Over half of global cardiovascular disease (CVD) deaths in 2019 happened in Asia - now, scientists are drawing attention to rapidly climbing figures, as heart issues continue to be a risk factor for severe COVID.
Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.
Scientists have discovered that up to 45% of people living with obesity have healthy blood pressure, glucose and lipid levels - protecting them from the risk of cardiovascular disease.
Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of the ETAHP Committee at the ESOT, explores a key area of development in heart transplant nursing as part of the build-up to ESOT Congress 2021.
Damaged heart muscle is a tragic possibility for patients of breast cancer chemotherapy - but thanks to Dr Husam Abdel-Qadir, there may now be a way to stop it.
Frank F Vincenzi, Professor Emeritus, University of Washington, tells us about the mammalian dive response (MDR), drawing on the case of the woman who developed a fatal heart rhythm while SCUBA diving.
According to the American Heart Association, women face a stronger heart attack risk than men - they are 20% more likely to develop heart failure, and to die.
Mhairi Brown, Policy and Public Affairs Manager for Action on Salt, stresses the need for Public Health England to implement a strict and ambitious salt reduction policy.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
Professor Lina Badimon and Elisabetta Zanon from the European Society of Cardiology provide their thoughts on understanding and addressing the impact of COVID-19 on heart disease.
